In a high competitive and growth market, MOEHS has been able to stand as one of the main participants worldwide.
THE KEY FACTORS THAT CONFIRMS THIS TREND ARE:
- Consolidation of a wide range of products with different therapeutic areas: from mucolytics to ß-blocants.
- Continuous enlargement of the API list.
- Optimum ratio between cost and services offered.
- Understanding of needs communicated by customers and transferring them to our product range.
- Documental and Regulatory support.